Effects of Riociguat on RIght VEntricular Size and Function in PAH and CTEPH

Clinical trial NCT04954742 · TERMINATED

Trial details

NCT number: NCT04954742
Sponsor: Heidelberg University
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Primary Pulmonary Arterial Hypertension Chronic Thromboembolic Pulmonary Hypertension

Start date: 2022-04-13
Primary completion: 2025-08-13
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.